Send me a link:

*Text messaging rates may apply.

 Dow Down 0.42% Nasdaq Down 0.52%

XOMA Corporation (XOMA)

-NasdaqGM
4.11 0.15(3.52%) Jul 10, 3:59PM EDT
Prev Close:4.26
Open:4.15
Bid:4.06 x 500
Ask:5.09 x 400
1y Target Est:9.00
Beta:2.71
Next Earnings Date:N/A
Day's Range:4.07 - 4.25
52wk Range:3.42 - 9.57
Volume:1,130,506
Avg Vol (3m):1,721,390
Market Cap:439.35M
P/E (ttm):N/A
EPS (ttm):-1.12
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
XOMADown 3.52%439.35M
NVS219.75B
REGN31.04B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):15.49
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.65
Quarterly EPS Est (Jun-14) :-0.21
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):-0.34

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

XOMA Corporation discovers and develops antibody-based therapeutics in the United States, Europe, and the Asia Pacific. Its proprietary products comprise gevokizumab, a humanized allosteric-modulating monoclonal antibody that binds to the inflamma... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback